 |
|
|
|
 |
|
|
| Article 1 to 6 out of 6 concerning Roslin Institute
|
-
Studies confirm proof-of-principle for Geron's Human Embryonic Stem Cell (HESC) derived hepatocytes
(04/23/2007)
Geron Corporation announced that it has developed standardized hepatocytes from human embryonic stem cells (hESCs) that can model human hepatic drug metabolism.Published in Cloning and Stem Cells (Vol. 9, No. 1, 51-62), a paper written by Geron's ...
-
GTC Biotherapeutics obtains license to nuclear transfer patents
(04/12/2007)
GTC Biotherapeutics, Inc. announced that it has been granted a non-exclusive worldwide license from Start Licensing, Inc., a joint venture between Geron Corporation and Exeter Life Sciences, Inc., for the patents and patent applications developed by ...
-
Viragen Reports Avian Transgenic Breakthrough: OVA(TM) System Expresses Interferon-Beta
(01/23/2006)
Viragen, Inc. announced that the Company's scientists, along with its collaborators at the Roslin Institute and Oxford BioMedica plc, have successfully achieved expression of significant quantities of the human protein, interferon beta-1a, in the ...
-
Lower-cost manufacturing for the production of many protein drugs by altering hens' genetic make-up
(07/20/2005)
Roslin Institute in Cancer Breakthrough
Scientists at Edinburgh's Roslin Institute have made a breakthrough in their battle to create designer eggs which may help to produce drugs to fight cancer.By altering hens' genetic make-up, the team has caused the synthesis in egg white of a ...
-
Viragen Reports Achievement of Key Avian Transgenics Milestone
(06/07/2005)
Anti-Cancer Antibody Expressed In Chicken Eggs Promises to Revolutionize Drug Production
Viragen, Inc., Roslin Institute (Scotland) and Oxford BioMedica PLC jointly announced a dramatic breakthrough in their pioneering project to develop Avian Transgenic Biomanufacturing with the report of a functional humanized antibody protein ...
-
Viragen Reports Advancement in Avian Transgenics Biomanufacturing
(02/21/2005)
Anti-cancer Antibody Expressed in Rooster
Viragen, Inc. announced an advancement in its program to develop avian transgenic biomanufacturing for the purpose of using chickens as bioreactors for the efficient and economical production of human pharmaceutical protein-based drugs in their ...
Additional information
Roslin Institute
United Kingdom
Company
|
|
|
|
|
|
Top
